United States · FDA National Drug Code directory
Deferasorox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-176_b2ff1a76-b564-4235-8275-89005d9c4a24
- Product NDC
- 72205-176
- Form
- GRANULE
- Composition / generic term
- Deferasirox
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220521
- Source listing expiry
- 20261231
Source-listed ingredients
- DEFERASIROX — 90 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 PACKET in 1 CARTON (72205-176-30) / 1 GRANULE in 1 PACKET (72205-176-61) · 72205-176-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →